Empowered Funds LLC lowered its holdings in Ultralife Co. (NASDAQ:ULBI – Free Report) by 57.0% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 14,510 shares of the technology company’s stock after selling 19,226 shares during the period. Empowered Funds LLC’s holdings in Ultralife were worth $131,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently added to or reduced their stakes in the company. O Shaughnessy Asset Management LLC acquired a new stake in Ultralife in the 1st quarter worth $100,000. Rhumbline Advisers lifted its stake in shares of Ultralife by 1,728.3% in the second quarter. Rhumbline Advisers now owns 11,811 shares of the technology company’s stock valued at $125,000 after buying an additional 11,165 shares during the period. Juncture Wealth Strategies LLC acquired a new stake in Ultralife during the third quarter worth about $165,000. Quadrature Capital Ltd bought a new position in Ultralife during the first quarter valued at about $200,000. Finally, XTX Topco Ltd raised its holdings in Ultralife by 192.1% in the 2nd quarter. XTX Topco Ltd now owns 37,399 shares of the technology company’s stock valued at $397,000 after acquiring an additional 24,595 shares in the last quarter. 30.68% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several brokerages recently commented on ULBI. StockNews.com cut Ultralife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, October 3rd. Benchmark reaffirmed a “buy” rating and set a $14.00 price objective on shares of Ultralife in a report on Friday, November 15th.
Ultralife Trading Up 3.6 %
ULBI opened at $7.81 on Wednesday. Ultralife Co. has a 1-year low of $6.36 and a 1-year high of $13.39. The stock has a market capitalization of $129.86 million, a PE ratio of 13.93 and a beta of 0.98. The company has a current ratio of 3.30, a quick ratio of 1.62 and a debt-to-equity ratio of 0.04. The firm has a 50-day moving average price of $8.74 and a two-hundred day moving average price of $10.00.
Ultralife Company Profile
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Read More
- Five stocks we like better than Ultralife
- What is a Secondary Public Offering? What Investors Need to Know
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- What is the Nikkei 225 index?
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Why Amazon Shares May Never Trade Below $200 Again
Want to see what other hedge funds are holding ULBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ultralife Co. (NASDAQ:ULBI – Free Report).
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.